000710.SZ
Berry Genomics Co., Ltd.
SZSE · Healthcare · M 科研服务 · CN
CNY 9.79
+6.41%Year over year
Reported trailing growth
- Revenue
- -9.3%
- EBITDA
- —
- EBIT
- -9.7%
- EPS
- -2.1%
- Free cash flow
- —
- Operating cash flow
- -85.9%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- -12.1%
- EBITDA
- -35.4%
- EBIT
- -12.4%
- Net income
- -2.3%
- EPS
- -2.3%
- Free cash flow
- —
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026